Recombinant Vaccines Market By Product (Attenuated, Vector, and Subunit), By Application (Veterinary and Human), By Disease (Hepatitis B, Cancer, Influenza, and Others), and By Distribution Channel (Hospitals, Clinics, Veterinary Clinics, Retail Pharmacies, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the recombinant vaccines market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the recombinant vaccines market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the recombinant vaccines market on a global and regional level.

In order to give the users a comprehensive view of the recombinant vaccines market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the recombinant vaccines market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the recombinant vaccines market on a global and regional basis.

The study provides a decisive view of the recombinant vaccines market by segmenting the market based on type, application, disease, distribution channel, and region. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players of the global recombinant vaccines market are Pfizer, Merck, Sanofi Pasteur, Bayer, GlaxoSmithKline, Serum Institute of India, Abiomed, Johnson & Johnson, Emergent Bio Solutions, and Mitsubishi Tanabe Pharma.

This report segments the global recombinant vaccines market as follows:

Global Recombinant Vaccines Market: By Type

	Attenuated
	Vector
	Subunit

Global Recombinant Vaccines Market: By Application

	Veterinary
	Human

Global Recombinant Vaccines Market: By Disease

	Hepatitis B
	Cancer
	Influenza
	Others

Global Recombinant Vaccines Market: By Distribution Channel

	Hospitals
	Clinics
	Veterinary Clinics
	Retail Pharmacies
	Others

Global Recombinant Vaccines Market: By Region

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa